Paradigm Pump Infusion System: Phase II started

Medtronic began the single-blind, U.S. Phase II COPE-HCV trial to compare continuous subcutaneous delivery of 3 dosages of Intron A interferon alfa-2b using Medtronic's Paradigm Pump Infusion System ...